Sandimmun, Konzentrat zur Herstellung einer Infusionslösung

7680449150141 CH-44915 Konzentrat
Sandimmun, Konzentrat zur Herstellung einer Infusionslösung
Sandimmun, Konzentrat zur Herstellung einer Infusionslösung
1 / 2
google

Article details

Package size
10 x 5
Selling units
10
Measure
ml
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/04/2026
Summary of Product Characteristics
Français
17/04/2026
Summary of Product Characteristics
Italien
17/04/2026

Detailed composition

Substance Quantity Type Category
ciclosporinum
50.0 MG Substance Wirkstoff (Principe actif)
ethanolum
261.0 MG Substance HBESI
macrogol 36 glyceroli ricinioleas
650.0 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 157.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
44915
Drug name
Sandimmun, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L04AD01
Authorization status
Z
Dispensing category
B
First authorization
28/12/1982
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Package details

Description (FR)
SANDIMMUN conc perf 250 mg/5ml 10 amp 5 ml
Description (DE)
SANDIMMUN Inf Konz 250 mg/5ml 10 Amp 5 ml
Market launch
28/12/1982
Narcotic (BTM)
No

Other package sizes (1)

SANDIMMUN conc perf 50 mg/ml 10 amp 1 ml
10 x 1 ML
GTIN: 7680449150301
View
Buy us a coffee Explore the data